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Abstract Although endovascular therapy has been proven
safe and has become in many centers the primary method of
treatment for intracranial aneurysms, the long-term durability
of endovascular embolization remains a concern; at least for
some aneurysms despite initial good result. While healing
after clipping relies on mechanical occlusion, restoration after
endovascular occlusion mainly requires the induction of a
biological response. Healing after embolization depends on
the growth of new tissue over the thrombus formed by the
embolization material, or alternatively, on the organization
of thrombus into fibrous tissue. This review highlights the
fundamental importance of aneurysm wall biology on the
healing process and long-term occlusion after intracranial an-
eurysm (IA) treatment. It seems likely that the effect of lumi-
nal thrombus on the IAwall, as well as the IAwall condition at
the time of thrombosis, determine if thrombus organizes into
scar tissue (neointima formation by infiltration of cells origi-
nating from the IA wall) or if the wall undergoes continuous
remodeling, which is primarily destructive (loss of mural
cells). In the latter, intraluminal thrombus organization fails
and the impaired healing increases the chance of recurrence.
Mechanisms underlying IA reopening, the influence of
intraluminal thrombosis on the IA wall, and clinical implica-
tions of the IA wall condition are discussed in detail, along
with how knowledge of IA wall biology can offer new solu-
tions for IA treatment and affect the patient selection for and
follow-up after endovascular treatment.
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Introduction
Intracranial aneurysms (IA) must be isolated from the cerebral
circulation to prevent rupture and subsequent devastating in-
tracranial hemorrhage. This was originally performed by li-
gating the artery at the site where the aneurysm originated.
With the development of microneurosurgical techniques, oc-
clusion of the aneurysm neck with a microsurgical clip
(clipping) became the golden standard for treatment. Later,
due to safe catheterization techniques for cerebral vessels
and surgical angiography, endovascular embolization with
thrombogenic coils (coiling) evolved and eliminated the need
for craniotomy and related manipulation of the brain itself.
One-year results of the largest randomized controlled trial
comparing clipping and coiling found less dependency or
death for patients with ruptured small anterior circulation IA
of good neurological grade [61]. Despite its criticism, the re-
sults of the study led to increased use of endovascular therapy
and eventually surpassed clipping as the most popular thera-
peutic approach for IAs. Although endovascular therapy has
been proven safe and effective, recurrence may occur even
after perfect packing of the aneurysm with coils (Table 1).
The variation in healing and long-term outcomes of embolized
aneurysms may be explained by aneurysm wall biology,
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which is fundamental to the healing of embolized aneurysms
and long-term success of endovascular therapy. Regarding the
term endovascular treatment (EVT), this review is mainly fo-
cused on standard coil embolization. Since, histological data
of the healing response induced by more recent embolization
devices is relatively scarce. The available published data, nev-
ertheless, demonstrates a similar healing response after novel
intrasaccular thrombogenic flow disruptive devices as after
standard coil embolization [19, 52, 58, 60]. Moreover, clinical
series demonstrate similar neck remnant and recanalization
problems after application of intrasaccular flow disruptive de-
vices, as after standard coil embolization [5, 74, 73, 88].
Initial occlusion does not guarantee long-term healing—a
problem of embolized aneurysms
The long-term success of any current therapy used to prevent
IA rupture is dependent on permanent occlusion of the IA
from the circulation. Embolized IA recur relatively frequently
despite good initial treatment results (Tables 1 and 2;
Supplementary Table 1). Many factors affect the risk of IA
recurrence after embolization [13, 65, 72, 78], and the natural
history of IA recurrence after embolization is poorly known.
However, it is clear that IA recurrence after embolization is
associated with a risk of rupture (although very low) and ne-
cessitates a higher rate of retreatment [9, 48, 63, 71]—or at the
minimum, additional follow-up that is prone to cause anxiety
in the patient [24].
Angiographic occlusion after EVTor after clipping is not to
be equated with biological healing [3, 50, 76, 80, 92, 93]. In a
long-term digital subtraction angiography study after coiling,
over 40% of patients with adequate IA occlusion at short-term
follow-up (< 36 months) demonstrated IA recurrence and
26% of these patients required retreatment [10]. Recurrence
and retreatment rates are even higher for patients with known
recurrence at short-term follow-up, 67 and 49%, respectively
[10].
Animal studies revealed significant discrepancy between
angiographic and histological findings resulting in overrated
radiologic occlusion after coil embolization [50, 80, 89].
Human histopathological studies confirmed these results and
demonstrated that half of IA deemed completely occluded on
angiography show tiny open spaces between the coils at the
neck [3]. When reviewing all published literature on human
Table 1 Recurrence in relation to
IA rupture status Authors (year) Follow-up (months) UIA n/n (% of recurrence) Ruptured IA n/n
(% of recurrence)
Cognard et al. [13] (1999) 3–48 4/54 (7) 16/94 (17)
Raymond et al. [74] (2003) 12 (mean) 52/190 (27) 76/191 (40)
Ngyen et al. [67] (2007) 20 (mean) 16/72 (22) 23/44 (52)
Tan et al. [91] (2011) 20–25 (mean) 10/49 (20) 19/47 (40)
Vanzin et al. [97] (2012) 21 (mean) 42/194 (22) 80/261 (31)
Abdihalim et al. [1] (2014) 9 (mean) 5/92 (5) 24/120 (20)
After EVT using mainly standard coils
Table 2 Recurrence in relation to IA size
Authors (year) Follow-up
(months)
Small IA < 10 mm n/n
(% of recurrence)
Large IA > 10 to ≤ 25 mm n/n
(% of recurrence)
Giant IA > 25 mm n/n
(% of recurrence)
Byrne et al. [7] (1999) 6–12 24/176 (14) 12/81 (15) 2/2 (100)
Tateshima et al. [92] (2000) 19 (mean) 2/24 (8) 4/10 (40) 4/8 (50)
Raymond et al. [74] (2003) 12 (mean) 47/221 (21) 81/160 (51) –
Murayama et al. [62] (2003) 6–12 66/579 (11) 70/198 (35) 43/73 (59)
Standhardt et al. [86] (2008)a 35 (mean) 22/163 (14) 5/20 (25) 9/19 (45)
Plowman et al. [70] (2011) 6 88/345 (26) 27/97 (28) 4/10 (40)
Gao et al. [32] (2012)b 38 (mean) – 6/53 (11) 10/28 (36)
Dorfer et al. [19] (2012) 6–18 61/403 (15) 66/173 (38) –
Chalouhi et al. [11] (2014)c 6–60 62/177 (35) 29/62 (47) 11/21 (52)
After EVT using mainly standard coils
a Small (< 12 mm) and large (13–24 mm) angiographic FU were available for 76% of all aneurysms
b Large (15–25 mm)
c Small (10–14 mm) and large (15–24 mm)
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histopathology after EVT, it can be concluded that transfor-
mation of intraluminal thrombosis into scar formation and re-
endothelialization of the luminal surface after EVT seems to
be the exception rather than the rule (Supplementary Table 2).
Recurrence after clipping—are problems with long-term
durability also associated with clipping?
In general, the reopening rate is lower in clipped than in coiled
IA [63, 90]. The largest study to date with the longest follow-
up data (mean, 7.2 ± 4.7 years) found that the risk of recur-
rence after clip ligation is 0.14% (1/699) and 13.6% (8/59) in
IA without residual and with residual neck on postoperative
imaging [6]. Previous series on long-term angiographic
follow-up (mean, 4.4 ± 1.6 years) found comparable increase
of IA recurrence with increase of residual aneurysm, 1.5%
(2/135), 25% (2/8), and 75% (3/4) in completely clipped IA,
known dog-ear, and broad-based remnant, respectively [16].
When a significant portion of the aneurysm wall is incorpo-
rated into the reconstructed vessel segment, the chance of
delayed recurrence is as high as 30% [102]. Drake and
Vanderlinden reported 0% (0/45), 17% (2/12), and 23%
(3/13) late rebleeding after surgical IA treatment with com-
plete obliteration, small remnant, or large remnant on postop-
erative angiography [21].
Histological analysis of clipped human IA demonstrated
that complete re-endothelialization and neointima formation
across the aneurysm neck occurred only in those IA with
100% exclusion of the diseased vessel wall (Supplementary
Table 2) [46]. This data demonstrates that IA clipping shares
many of the challenges of IA coiling. If microsurgical clipping
fails to realign normal arterial tissue, recurrence rate is similar
that found after endovascular coiling.
Clipping vs. coiling—mechanical vs. biological healing
There is a fundamental difference in the way clipping and
coiling prevent IA rupture. Aneurysm clips exclude the
diseased vessel segment, close the aneurysm neck and realign
healthy arterial walls (Fig. 1).When successful, the clip blades
pull the opposing healthy vessel walls towards each other (if
the parent artery segment is not diseased), immediately
reconstituting the affected vessel segment. Conventional his-
tological and electron microscopy results after experimental
clipping show a completely reconstructed normal vessel wall,
with endothelialization across the aneurysm neck directly be-
low the clip blades [50]. However, in clipped human IA, the
effectiveness of treatment is mainly related to the mechanics
of vessel reconstruction rather than the slow biological healing
process (endothelialization and neointima formation) [46].
In embolization, the aneurysm sac is filled with material
that will induce thrombosis but – at least initially – keeps the
aneurysm neck open, separates adjacent healthy tissue and
prevents realignment of the endothelium of the diseased arte-
rial segment (Fig. 1). Healing after embolization requires the
growth of new tissue over the thrombus, or the organization of
the thrombus into fibrous tissue (Supplementary Table 2). In
summary, healing after clipping relies on mechanical occlu-
sion, whereas healing after coiling mainly requires the induc-
tion of a biological response.
Mechanisms for recurrence of embolized aneurysms—a
mechanical or biological problem?
Themechanisms underlying reopening are poorly understood.
Most hypotheses are based on subjective interpretation of
morphological IA changes. IA volume-oriented mechanisms
include coil compaction, coil migration into intraluminal
thrombus, and resorption of pre-existing intraluminal throm-
bus [8, 42, 50, 100].
Human histopathological studies after Guglielmi detach-
able coil (GDC) embolization revealed that the unorganized
intraluminal thrombus organizes itself by creating granulation
tissue; first at the aneurysmwall, followed by the expansion of
the endothelial cell lining over the granulation tissue at the
aneurysm neck [3]. Based upon these findings and the
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Fig. 1 Aneurysm healing after clipping vs. after coiling. a Schematic
illustration of an IA with healthy parent arteries (blue vessel wall) and
diseased bulging segment (thinner gray aneurysm wall). b Aneurysm
clips exclude the diseased vessel segment, close the aneurysm neck,
realign healthy arterial walls (black arrows), and exclude the
thrombosed IA lumen from the circulation. c In IA coiling, the healthy
transition zone at the neck is not realigned (black arrows). The coils hold
the neck open, induce intraluminal thrombosis, and prevent exclusion of
the diseased arterial segment until neointima forms over the aneurysm
orifice or the thrombus organizes into fibrous tissue. In summary, healing
after clipping requires mechanical occlusion while healing after coiling
mainly depends on the induction of a biological response
confirmation of the healing processes in experimental settings,
deficient fibrosis, insufficient neointima, and lack of endothe-
lialization may tentatively be seen as mechanisms of IA recur-
rence [14, 15, 17, 50, 79].
Based on extensive experience with canine carotid bifurca-
tion aneurysm models, Raymond et al. found that, following
GDC occlusion, thrombus organization, endothelialization,
and neointima formation take place at the same time as IA
recurrence. They presented an alternative concept and pro-
posed that connective tissue contraction leads to fibrosed cav-
ity shrinkage [76]. This results in displacement towards the
fundus, the opening of recurring space, progressive enlarge-
ment, and coil compaction. Cognard et al. [13] found regrowth
after subtotal occlusion to be more frequent than true recur-
rences and emphasized that aneurysm growth might be an
important factor for IA recurrence. They hypothesized that
IA growth is related to coil compaction in that regrowth may
produce changes in the coil mesh, or conversely, that round
coil compaction could lead to recanalization of the neck and
restart the IA growth process.
Rigorous three-dimensional image analysis of IA
reopening revealed that not only coil compaction but also
aneurysm growth is an important mechanism for recurrence
of initially complete or near-complete obliteration [35].
Comparison of coil mass and the area surrounding aneurysm
sacs in 29 patients with significant IA recurrence (24/29 pa-
tients with ruptured IA status) points to IA growth as the
leading cause in more than half of the cases (62%; 18 patients)
[1]. A study minimizing image analysis bias by using non-
recurrence control subjects and automated image analysis pro-
tocols demonstrated that aneurysm sac growth is the predom-
inant etiology of IA recurrence after coil embolization [39].
The fact that recurrence in patients with multiple aneurysm is
higher than the subpopulation of patients with single IA sup-
ports the hypotheses that biological processes are responsible
for IA recurrence after EVT using standard coils [101].
The fundamental difference between ruptured
and unruptured IA
Raymond et al. studied IA recurrence after embolization and
was not able to explain the significant difference in recurrence
between unruptured and ruptured IA based on factors such as
aneurysm size, neck width, or quality of initial angiographic
results [78]. They therefore assumed that biological differ-
ences must exist. The difference in recurrence rate after EVT
between ruptured and unruptured IAs is a solid finding
(Table 1) [1, 13, 70, 78, 95, 101]. Analysis of a matched
(aneurysm location, diameter, and neck size) cohort demon-
strated not only an overall higher risk of recanalization in
ruptured IA but also shorter period and higher degrees of
recanalization and a higher percentage of retreatment when
compared with unruptured IA [95]. It is increasingly
recognized that the need of retreatment after GDC emboliza-
tion are more common in ruptured than unruptured IA [20, 38,
64, 71, 72].
Ruptured and unruptured IAs most likely represent differ-
ent biological entities. Human histopathological series clearly
demonstrate underlying differences in aneurysm morphology
between ruptured and unruptured IA. Ruptured aneurysms are
associated with wall degeneration and some exhibit extremely
thin thrombosis-lined hypo- to acellular walls, with
degenerated extracellular matrix and loss of endothelial cells
[29, 44]. We hypothesize that this type of IAs with loss of
smooth muscle cells (SMC) are not only prone to growth
and rupture [27] but also lack the capacity to organize throm-
bus, which could explain the significantly higher recurrence
rate after embolization of ruptured IA.
Intraluminal thrombosis destabilizes the IAwall
and influence healing
Acute thrombus induction has been linked to mural destabili-
zation not only in experimental aneurysms [4, 56, 57, 77] but
also in clinical settings after endovascular therapy [23, 34, 51,
66]. Various degrees of inflammation may exist depending on
both the volume of induced thrombus and the IAwall condi-
tion at the time of EVT (wall enhancement is less common in
ruptured than unruptured IA) [23]. Aneurysm wall enhance-
ment is found in 32–64% after EVTand may not be patholog-
ical per se but rather part of a normal healing response [23,
91]. Increased aneurysm size and the associated large throm-
bus volume after GDC embolization is an independent predic-
tor of IA wall enhancement [23, 40, 91]. Aneurysm wall and
perianeurysmal inflammation is frequently encountered in
partially thrombosed aneurysms which provide further evi-
dence that intraluminal thrombosis contributes significantly
to IAwall inflammation [23, 49].
Approximately 70% of aneurysm volume is filled with
thrombus following coil embolization [12, 83, 94].
Recanalization has been linked to a packing volume with
higher recurrence rates in aneurysms in over 80% of
intraluminal thrombus [41, 45, 53, 81, 86, 94, 97, 100].
Increasing packing volumes is more difficult to achieve in
larger aneurysms. Packing density is inversely related to an-
eurysm volume with higher amounts of thrombus in larger
aneurysms [47, 86, 98]. In experimental aneurysms, volume
was negatively correlated with packing density, and histolog-
ical healing was negatively correlated with aneurysm size
[18]. Both thrombus organization and neointima formation
were superior in aneurysms with less thrombus. Small aneu-
rysm size was found to be associated with stable long-term
results after coiling, irrespective of IA location [87].
Histologically, confirmed complete healing after coiling tends
to be found only in small IA (Supplementary Table 2).
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Coil packing density is particularly poor in large and
giant aneurysms which leads to > 95% of intraluminal
thrombus and recurrence rates of > 50% [7, 11, 25, 62, 85,
96, 99]. Overall, recurrence rates for small aneurysms (4–
10 mm) are reported to be 5–20%, depending on neck size
[65]. This increases to 35–50% in large (10–25 mm) and
60–90% in giant aneurysms (Table 2) [32, 33, 65, 78]. The
presence of intraluminal thrombosis alone is a possible risk
factor for a coiled IA reopening [25, 69, 71, 72, 96, 100,
102]. Large aneurysm size is not only a risk factor for IA
recurrence but also raises the need for retreatment after
EVT [9, 71, 72].
Overall, it seems likely that the effect of luminal thrombus
on the IAwall as well as the IAwall condition at the time of
thrombosis determine if thrombus organizes into scar tissue
(neoint ima format ion by inf i l t ra t ion of SMC or
myofibroblasts) or if the wall will undergo continuous remod-
eling (driven by inflammatory processes which are primarily
destructive). In the latter case, intraluminal thrombus organi-
zation fails and impaired healing makes the IA more suscep-
tible to recurrence.
Implications of wall pathology on aneurysm healing—an
explanation for posttreatment recurrence?
In experimental models of saccular aneurysm, most thrombus
organizing neointima cells are derived from the aneurysm
wall—with a possible negligible contribution from circulating
bone marrow cells [28, 37]. The finding that intraluminal un-
organized thrombus is mainly organized by IAwall cells is in
line with human histological studies after GDC embolization
which found that granulation tissue response starts at the pe-
riphery of the luminal clot adjacent to the aneurysm wall
(Supplementary Table 2) [2, 3, 62, 68, 84]. However, many
processes of aneurysm healing are not well understood and
remain controversial. Recent studies suggest that also bone
marrow-derived endothelial progenitor and not only parent
artery endothelial cells contribute to re-endothelialization at
the aneurysm neck [54, 103]. Furthermore, in a murine elas-
tase saccular model, monocyte chemotactic protein-1-coated
coils were capable to recruit bone marrow-derived fibroblasts
and macrophages via macrophage inflammatory protein-
dependent pathways [36].
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Fig. 2 The natural course of aneurysm healing after coiling is not solely
dictated by the angioarchitecture of the aneurysm; it is largely determined
by the condition of the aneurysm wall. Schematic illustration comparing
healing after coiling in IA with many functioning SMC (a, thick blue
aneurysm wall) and IA with highly degenerated walls and loss of SMC
(b, thin gray aneurysm wall). In healthy wall IA, coiling induces
intraluminal thrombosis (a1, dark red areas), SMC undergo phenotypic
modulation, migrate into the thrombus (a2, blue dots), and transform it
into scar tissue (a3, green areas). EVT also induces intraluminal
thrombosis in IAs with a degenerated wall (b1, dark red areas).
Missing mural cells, however, prevent thrombus organization and
recanalization (b2, red areas) and may further damage the aneurysm
wall which potentially cause progression of the disease (b3,
enlargement and recurrence). c Histology of a healed rat sidewall
aneurysm (green area with intraluminal connective tissue formation
(asterisk)) with a vital wall full of SMCs (black arrows). d
Unorganized thrombus (red area with fibrin mesh (double asterisks)
and red blood cells (triple asterisks)) in an experimental aneurysm with
missing mural cells (black arrows)
Many IA walls lack the SMCs that are meant to organize
the thrombus induced by embolization and thus permanently
heal the embolized aneurysm [27, 29, 44]. This loss of SMCs
slows thrombus organization, causing the embolized IA to
remain in an unstable state of continuous coagulation cas-
cade—with subsequent activation of clot lysis pathways.
This can eventually lead to clot lysis, recanalization, and IA
recurrence. Moreover, experimental models have demonstrat-
ed that continuous exposure of the unorganized thrombus to
the circulation can promote recruitment of neutrophils and
inflammatory cells [55, 57], which increase proteolytic injury
to the IAwall [30]. Unruptured IAs tend to have more viable
SMCs in their walls, providing unruptured IAs increased op-
portunity to heal after embolization. This could explain why
unruptured IAs have lower rebleeding rates [20, 75], necessi-
tate less retreatment [20, 31, 38, 71, 72, 82], and are more
stable after GCD embolization than ruptured IAs [1, 13, 26,
43, 70–72, 78, 95, 101].
We demonstrated in an experimental aneurysm model how
the loss of SMCs from the aneurysm wall leads to growth and
rupture, with concomitant wall inflammation and neutrophil
recruitment [57], as well as how thrombus organization and
prevention of aneurysm growth and rupture is significantly
dependent on the presence of healthy SMCs in the aneurysm
wall [55]. The contribution of bone marrow-derived cells to
intra-aneurysmal tissue healing might vary in relation to the
aneurysm wall condition (loss of mural cells).
The experimental data confirms the importance of aneu-
rysm wall SMCs and—together with histopathological data
from human IAs—strongly suggests that loss of this particular
cell population could explain the failure of EVT in patients.
IAs with a decellularized wall are less likely to heal properly
after EVT as they lack the capacity for thrombus organization
(Fig. 2).
Why knowledge of aneurysm wall biology can offer new
solutions
The biology of the aneurysm wall determines the risk of rup-
ture as well as the biological potential for healing. Although
risk factors influencing IA recurrence and the need for
retreatment have been identified [71, 72], it remains difficult
to determine which IA will reopen after EVT and which will
not. A growing body of evidence emphasizes the paramount
importance of the aneurysm wall condition in IA growth and
recurrence after EVT.
IA walls can be imaged with modern MRI techniques al-
ready available for clinical use [22, 59, 67]. This enables us to
study different aspects of their biology and condition in pa-
tients in a clinical setting. Gadolinium uptake on T1 was more
frequently observed in unstable IA [22] and has been associ-
ated with major recurrence after embolization [23].
Other MRI techniques able to identify IAwalls with mural
SMC loss have considerable potential as diagnostic tools to
help designate patients for endovascular or microsurgical in-
tervention. In cases where endovascular intervention has been
selected, they could help identify which embolized IAs are
likely to recur and necessitate retreatment. The development
ofMRI or other imaging methods to identify decellularized IA
walls with loss of SMCs is urgently needed.
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